Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis.

Bellisai F, Morozzi G, Scaccia F, Chellini F, Simpatico A, Pecetti G, Galeazzi M.

Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):261-4.

PMID:
21496413
[PubMed - indexed for MEDLINE]
2.

Bosentan in systemic sclerosis.

Heresi GA, Minai OA.

Drugs Today (Barc). 2008 Jun;44(6):415-28. doi: 10.1358/dot.2008.44.6.1220138. Review.

PMID:
18596996
[PubMed - indexed for MEDLINE]
3.

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C.

Arthritis Rheum. 2004 Dec;50(12):3985-93.

PMID:
15593188
[PubMed - indexed for MEDLINE]
Free Article
4.

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.

Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P, Stefanadis C, Mavrikakis M.

Arthritis Rheum. 2007 Jun;56(6):1985-93.

PMID:
17530638
[PubMed - indexed for MEDLINE]
Free Article
5.

[Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].

Launay D, Diot E, Pasquier E, Mouthon L, Boullanger N, Fain O, Jego P, Carpentier P, Hatron PY, Hachulla E.

Presse Med. 2006 Apr;35(4 Pt 1):587-92. French.

PMID:
16614599
[PubMed - indexed for MEDLINE]
Free Article
6.

Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension.

Iannone F, Riccardi MT, Guiducci S, Bizzoca R, Cinelli M, Matucci-Cerinic M, Lapadula G.

Ann Rheum Dis. 2008 Aug;67(8):1121-6. Epub 2007 Nov 20.

PMID:
18029384
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.

Giannelli G, Iannone F, Marinosci F, Lapadula G, Antonaci S.

Curr Med Res Opin. 2005 Mar;21(3):327-32.

PMID:
15811199
[PubMed - indexed for MEDLINE]
8.

Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.

Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, De Pità O, Puddu P, Paganelli R, Russo G.

Clin Exp Immunol. 2004 Dec;138(3):540-6.

PMID:
15544634
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.

Jain M, Varga J.

Expert Opin Pharmacother. 2006 Aug;7(11):1487-501. Review.

PMID:
16859432
[PubMed - indexed for MEDLINE]
10.

Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial.

Kuhn A, Haust M, Ruland V, Weber R, Verde P, Felder G, Ohmann C, Gensch K, Ruzicka T.

Rheumatology (Oxford). 2010 Jul;49(7):1336-45. doi: 10.1093/rheumatology/keq077. Epub 2010 Apr 5.

PMID:
20371505
[PubMed - indexed for MEDLINE]
Free Article
11.

Bosentan fosters microvascular de-remodelling in systemic sclerosis.

Guiducci S, Bellando Randone S, Bruni C, Carnesecchi G, Maresta A, Iannone F, Lapadula G, Matucci Cerinic M.

Clin Rheumatol. 2012 Dec;31(12):1723-5. doi: 10.1007/s10067-012-2074-5. Epub 2012 Sep 29.

PMID:
23053682
[PubMed - indexed for MEDLINE]
12.

Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.

Rosato E, Molinaro I, Borghese F, Rossi C, Pisarri S, Salsano F.

J Rheumatol. 2010 Dec;37(12):2531-9. doi: 10.3899/jrheum.100358. Epub 2010 Sep 1.

PMID:
20810512
[PubMed - indexed for MEDLINE]
13.

Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.

Dhillon S.

Drugs. 2009 Oct 1;69(14):2005-24. doi: 10.2165/10489160-000000000-00000. Review.

PMID:
19747014
[PubMed - indexed for MEDLINE]
14.

Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.

Cozzi F, Pigatto E, Rizzo M, Favaro M, Zanatta E, Cardarelli S, Riato L, Punzi L.

Clin Rheumatol. 2013 May;32(5):679-83. doi: 10.1007/s10067-013-2172-z. Epub 2013 Jan 24.

PMID:
23344686
[PubMed - indexed for MEDLINE]
15.

Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.

Antonelli A, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Di Domenicantonio A, Ferri C.

J Rheumatol. 2012 May;39(5):979-85. doi: 10.3899/jrheum.111132. Epub 2012 Mar 15.

PMID:
22422499
[PubMed - indexed for MEDLINE]
16.

Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.

Giordano N, Puccetti L, Papakostas P, Di Pietra N, Bruni F, Pasqui AL, Acampa M, Bocchi V, Donati V, Voglino M, Fioravanti A, Montella A, Auteri A, Nuti R, Pastorelli M.

Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1185-94.

PMID:
21244767
[PubMed - indexed for MEDLINE]
17.

[Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].

Riccardi MT, Chialà A, Lannone F, Grattagliano V, Covelli M, Lapadula G.

Reumatismo. 2007 Apr-Jun;59(2):135-9. Italian.

PMID:
17603693
[PubMed - indexed for MEDLINE]
18.

Bosentan for digital ulcers in patients with systemic sclerosis.

Nagai Y, Hasegawa M, Hattori T, Okada E, Tago O, Ishikawa O.

J Dermatol. 2012 Jan;39(1):48-51. doi: 10.1111/j.1346-8138.2011.01299.x. Epub 2011 Sep 28.

PMID:
21955007
[PubMed - indexed for MEDLINE]
19.

Successful treatment with bosentan for pulmonary hypertension and reduced peripheral circulation in juvenile systemic sclerosis.

Shimizu M, Hashida Y, Ueno K, Yokoyama T, Nakayama Y, Saito T, Ohta K, Takehara K, Yachie A.

Pediatr Cardiol. 2011 Oct;32(7):1040-2. doi: 10.1007/s00246-011-0056-z. Epub 2011 Jul 26.

PMID:
21789477
[PubMed - indexed for MEDLINE]
20.

Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy.

Kawashiri SY, Ueki Y, Terada K, Yamasaki S, Aoyagi K, Kawakami A.

Rheumatol Int. 2014 Feb;34(2):221-5. doi: 10.1007/s00296-013-2861-6. Epub 2013 Sep 27.

PMID:
24071933
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk